Literature DB >> 35935920

Synthesis of a boron-containing amidoxime reagent and its application to synthesize functionalized oxadiazole and quinazolinone derivatives.

Bhaskar C Das1,2,3, Nitesh K Nandwana1,2, Devi P Ojha2, Sasmita Das2, Todd Evans3.   

Abstract

Herein, we report the design, synthesis and application of a borylated amidoxime reagent for the direct synthesis of functionalized oxadiazole and quinazolinone derivatives. This reagent exhibits broad synthetic utility to obtain a variety of biologically relevant drug-like molecules. It can be easily prepared at large scale from relatively inexpensive reagents, and can undergo facile transformations to obtain target compounds. The developed amidoxime reagent was synthesized from 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile and hydroxyl amine hydrochloride using N,N-diisopropylethylamine as a base in ethanol under reflux conditions. Overall advantages include a metal-free route to boronated oxadiazoles, quinazolinone derivatives, and restriction of the multistep sequences. Importantly, the boron-rich pharmacophore derived compounds were obtained through an efficient and inexpensive strategy.

Entities:  

Keywords:  Boron based Therapeutics; Boron containing Amidoxime; Imidazo[1,2-a]pyridine; Oxadiazoles; Quinazolinone

Year:  2022        PMID: 35935920      PMCID: PMC9348647          DOI: 10.1016/j.tetlet.2022.153657

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.032


  42 in total

1.  Synthesis of 2-substituted 2H-chromenes using potassium vinyltrifluoroborates.

Authors:  Fei Liu; Todd Evans; Bhaskar C Das
Journal:  Tetrahedron Lett       Date:  2008-03-03       Impact factor: 2.415

Review 2.  A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology.

Authors:  Farah Moustafa; Steven R Feldman
Journal:  Dermatol Online J       Date:  2014-05-16

Review 3.  The versatility of boron in biological target engagement.

Authors:  Diego B Diaz; Andrei K Yudin
Journal:  Nat Chem       Date:  2017-07-25       Impact factor: 24.427

4.  Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum.

Authors:  G R Pettit; S B Singh; M L Niven; E Hamel; J M Schmidt
Journal:  J Nat Prod       Date:  1987 Jan-Feb       Impact factor: 4.050

5.  Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.

Authors:  G D Diana; D L Volkots; T J Nitz; T R Bailey; M A Long; N Vescio; S Aldous; D C Pevear; F J Dutko
Journal:  J Med Chem       Date:  1994-07-22       Impact factor: 7.446

6.  In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate.

Authors:  Xiaoying Hui; Stephen J Baker; Ronald C Wester; Sherry Barbadillo; Anne K Cashmore; Virginia Sanders; Karin M Hold; Tsutomu Akama; Yong-Kang Zhang; Jacob J Plattner; Howard I Maibach
Journal:  J Pharm Sci       Date:  2007-10       Impact factor: 3.534

7.  Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

Authors:  Philippe Moreau; Tamás Masszi; Norbert Grzasko; Nizar J Bahlis; Markus Hansson; Ludek Pour; Irwindeep Sandhu; Peter Ganly; Bartrum W Baker; Sharon R Jackson; Anne-Marie Stoppa; David R Simpson; Peter Gimsing; Antonio Palumbo; Laurent Garderet; Michele Cavo; Shaji Kumar; Cyrille Touzeau; Francis K Buadi; Jacob P Laubach; Deborah T Berg; Jianchang Lin; Alessandra Di Bacco; Ai-Min Hui; Helgi van de Velde; Paul G Richardson
Journal:  N Engl J Med       Date:  2016-04-28       Impact factor: 91.245

8.  Design and synthesis of 3,5-disubstituted boron-containing 1,2,4-oxadiazoles as potential combretastatin A-4 (CA-4) analogs.

Authors:  Bhaskar C Das; Xiang-Ying Tang; Patrick Rogler; Todd Evans
Journal:  Tetrahedron Lett       Date:  2012-08-01       Impact factor: 2.415

9.  Efficient hydrolysis of organotrifluoroborates via silica gel and water.

Authors:  Gary A Molander; Livia N Cavalcanti; Belgin Canturk; Po-Shen Pan; Lauren E Kennedy
Journal:  J Org Chem       Date:  2009-10-02       Impact factor: 4.354

Review 10.  Vascular targeted therapies in oncology.

Authors:  Dietmar W Siemann; Michael R Horsman
Journal:  Cell Tissue Res       Date:  2008-08-28       Impact factor: 5.249

View more
  1 in total

1.  A novel procedure for the synthesis of borylated quinolines and its application in the development of potential boron-based homeodomain interacting protein kinase 2 (HIPK2) inhibitors.

Authors:  Bhaskar C Das; Pratik Yadav; Sasmita Das; John Cijiang He
Journal:  RSC Adv       Date:  2022-08-25       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.